Donald Trump Announces Pharma Deal: List of Drugs Getting Prices Reduced
Summary
President Donald Trump announced new agreements with nine drug companies to lower prices on certain medicines in the United States. These deals are part of his administration’s plan to match U.S. drug prices with the lowest prices paid in other developed countries.Key Facts
- The agreements include nine companies: Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB.
- The total number of drugmakers in the program now stands at 26, covering about 89% of branded drugs in the market.
- The drug price policy is called the "Most Favored Nation" (MFN) pricing, aiming to lower U.S. prices to those in other wealthy countries.
- Some specific medicines with price cuts include treatments for seizures, transplants, infections, blood pressure, hemophilia, Parkinson’s disease, and various cancers.
- Companies agreed to provide these lower prices to state Medicaid programs, helping generate savings for the government and patients.
- The policy began in 2025 when President Trump revived the MFN pricing rule through executive action.
- The White House also supports TrumpRx, a program letting drug companies sell certain medicines directly to patients at cheaper prices.
- The overall goal is to reduce drug costs, which have been higher in the U.S. than in other developed countries for many years.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
